As part of our commitment to our patients, Chicago ENT’s research team is always conducting research and is frequently involved in clinical trials. Our physicians are thus integral in developing the most cutting-edge, effective treatments available. In addition, it enables Chicago ENT to live up to its name as an Advanced Center for Specialty Care, providing our patients with a host of alternative treatment options. To inquire about our ongoing research and clinical trials, please call (773) 296-5500.
Current: For The Treatment of Uncontrolled Asthma in Adolescence (12 and Up) and Adults
A Randomized, Double-Blind, Double Dummy, Parallel Group, Multicenter 24 to 52 Week Variable Length Study to Assess the Efficacy and Safety of Budesonide, Glycopyrronium, and Formoterol Fumarate Metered Dose Inhaler (MDI) Relative to Budesonide and Formoterol Fumarate MDI and Symbicort® Pressurized MDI in Adult and Adolescent Participants with Inadequately Controlled Asthma (KALOS)
Current: For The Continued Treatment or Chronic Rhinosinusitis and Nasal Polyps in Adults Following Nasal Polyps Surgery
A Multicentre, Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Phase 3 Efficacy and Safety Study of Benralizumab for the Prevention of Recurrence of Nasal Polyps Following Surgical Removal in Patients with Chronic Rhinosinusitis with Nasal Polyps (OXALIS)